Tags

Type your tag names separated by a space and hit enter

[Fibromyalgia syndrome treated with acupuncture at the acupoints of the affected meridians and heavy moxibustion at painful points: a randomized controlled trial].
Zhongguo Zhen Jiu 2016; 36(2):147-51ZZ

Abstract

OBJECTIVE

To observe the clinical efficacy on fibromyalgia syndrome treated with acupuncture at the acupoints selected from the affected meridians based on the location differentiation and the heavy moxibustion at painful points by the randomized controlled trial with medication.

METHODS

Thirty-two patients of fibromyalgia were randomized into an acupuncture-moxihustion group and a medication group, 16 cases in each one. In the acupuncture-moxibustion group, acupuncture at the acupoints selected from the affected meridians based on the location differentiation and the heavy moxibustion at painful points were applied, once every two days, three times a week, for 4 weeks totally. In the medication group, tramadol sustained release tablets and amitriptyline were prescribed for oral administration, once a day, for 4 weeks. The follow-up visit was conducted for 4 weeks in the two groups. Before and after treatment and in follow-up visit, the revised version of the fibromyalgia impact questionnaire (FIQR) and visual analogue scale (VAS) were adopted for assessment and comparison of the efficacy between the two groups.

RESULTS

After treatment and in follow-up visit, FIQR score and VAS score were improved apparently as compared with those before treatment in the two groups (all P<0. 05). At the end of treatment, the differences were not significant statistically between the two groups (all P>0. 05). But the differences were significant in follow-up visit (all P<0. 05). The scores in the acupuncture-moxibustion group were improved persistently, but those in the medication group were rebound.

CONCLUSION

The acupuncture at the acupoints selected from the affected meridians based on the location differentiation and the heavy moxibustion at painful points are safe and effective in the treatment of fibromyalgia syndrome and present the better persistent effect as compared with the combined medication of tramadol sustained release tablets and amitriptyline.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

chi

PubMed ID

27348913

Citation

Li, Dehua, et al. "[Fibromyalgia Syndrome Treated With Acupuncture at the Acupoints of the Affected Meridians and Heavy Moxibustion at Painful Points: a Randomized Controlled Trial]." Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion, vol. 36, no. 2, 2016, pp. 147-51.
Li D, Yang L, Li J. [Fibromyalgia syndrome treated with acupuncture at the acupoints of the affected meridians and heavy moxibustion at painful points: a randomized controlled trial]. Zhongguo Zhen Jiu. 2016;36(2):147-51.
Li, D., Yang, L., & Li, J. (2016). [Fibromyalgia syndrome treated with acupuncture at the acupoints of the affected meridians and heavy moxibustion at painful points: a randomized controlled trial]. Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion, 36(2), pp. 147-51.
Li D, Yang L, Li J. [Fibromyalgia Syndrome Treated With Acupuncture at the Acupoints of the Affected Meridians and Heavy Moxibustion at Painful Points: a Randomized Controlled Trial]. Zhongguo Zhen Jiu. 2016;36(2):147-51. PubMed PMID: 27348913.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Fibromyalgia syndrome treated with acupuncture at the acupoints of the affected meridians and heavy moxibustion at painful points: a randomized controlled trial]. AU - Li,Dehua, AU - Yang,Ling, AU - Li,Ji, PY - 2016/6/29/entrez PY - 2016/6/29/pubmed PY - 2016/7/28/medline SP - 147 EP - 51 JF - Zhongguo zhen jiu = Chinese acupuncture & moxibustion JO - Zhongguo Zhen Jiu VL - 36 IS - 2 N2 - OBJECTIVE: To observe the clinical efficacy on fibromyalgia syndrome treated with acupuncture at the acupoints selected from the affected meridians based on the location differentiation and the heavy moxibustion at painful points by the randomized controlled trial with medication. METHODS: Thirty-two patients of fibromyalgia were randomized into an acupuncture-moxihustion group and a medication group, 16 cases in each one. In the acupuncture-moxibustion group, acupuncture at the acupoints selected from the affected meridians based on the location differentiation and the heavy moxibustion at painful points were applied, once every two days, three times a week, for 4 weeks totally. In the medication group, tramadol sustained release tablets and amitriptyline were prescribed for oral administration, once a day, for 4 weeks. The follow-up visit was conducted for 4 weeks in the two groups. Before and after treatment and in follow-up visit, the revised version of the fibromyalgia impact questionnaire (FIQR) and visual analogue scale (VAS) were adopted for assessment and comparison of the efficacy between the two groups. RESULTS: After treatment and in follow-up visit, FIQR score and VAS score were improved apparently as compared with those before treatment in the two groups (all P<0. 05). At the end of treatment, the differences were not significant statistically between the two groups (all P>0. 05). But the differences were significant in follow-up visit (all P<0. 05). The scores in the acupuncture-moxibustion group were improved persistently, but those in the medication group were rebound. CONCLUSION: The acupuncture at the acupoints selected from the affected meridians based on the location differentiation and the heavy moxibustion at painful points are safe and effective in the treatment of fibromyalgia syndrome and present the better persistent effect as compared with the combined medication of tramadol sustained release tablets and amitriptyline. SN - 0255-2930 UR - https://www.unboundmedicine.com/medline/citation/27348913/[Fibromyalgia_syndrome_treated_with_acupuncture_at_the_acupoints_of_the_affected_meridians_and_heavy_moxibustion_at_painful_points:_a_randomized_controlled_trial]_ L2 - http://www.diseaseinfosearch.org/result/2854 DB - PRIME DP - Unbound Medicine ER -